Ultrahuman, the Bengaluru-based health-tech innovator, has raised ₹100 crore in venture debt from Alteria Capital, marking a major milestone in its expansion journey. The company, known for its smart wearables and metabolic health products, aims to use this fresh capital to scale its product ecosystem, strengthen its technology, and push deeper into global markets. The raise comes at a crucial time when consumer interest in health tracking is rising worldwide and Ultrahuman is positioning itself as one of the top global contenders in the smart wellness space.
Strengthening Product Innovation and Expansion
With this new funding, Ultrahuman plans to bring even more innovation to its fast-growing lineup of devices, including its popular smart ring, continuous glucose monitoring tools, and health-tracking software. The company has stated that the capital will be directed toward expanding manufacturing capabilities, improving scientific research behind its products, and strengthening its software platform, which is becoming a major contributor to revenue. By simplifying health metrics and offering actionable insights, Ultrahuman aims to make wellness more accessible to people of all ages, including young users who are just beginning to explore fitness and lifestyle tracking. The company believes that the combination of hardware and software will set new benchmarks for personalized health monitoring.
Strong Financial Performance Fuels Investor Confidence
One of the key reasons behind Alteria Capital’s confidence is Ultrahuman’s significant improvement in financial performance. The company reported operating revenue of around ₹565 crore in FY25, with the United States contributing nearly 60 percent of its total earnings. Even more impressive is the shift from losses to profitability, with Ultrahuman recording a net profit of ₹73 crore in the same period. Such results highlight the growing demand for the company’s products and its ability to scale efficiently. Ultrahuman has also shared that it is on track to reach an annual revenue run rate of ₹1,100 crore in FY26, driven by increasing global adoption and continued interest in its smart wearable ecosystem. These numbers underline the company’s strong fundamentals and long-term growth potential.
Navigating Challenges in the Global Market
Despite its strong performance, Ultrahuman is also navigating challenges, particularly in the United States, where it faces a legal dispute with wearable brand Oura. The issue has resulted in temporary import restrictions on some Ultrahuman ring models. However, the company has taken legal action and is also exploring alternative manufacturing options, including production at its Texas facility, to continue serving U.S. customers. This setback has not slowed the company’s momentum, as demand for its devices continues to rise across multiple regions. Ultrahuman remains confident that its scientific approach, product quality, and expanding partnerships with researchers and athletes will help reinforce its global position.
A Confident Step Toward Global Leadership
The ₹100 crore debt raise represents more than just funding; it reflects trust in Ultrahuman’s mission to transform personal health tracking. With a focus on innovation, global expansion, and sustainable growth, the company is steadily moving toward becoming one of the world’s leading health-tech platforms. By building products that are easy to use, data-driven, and truly helpful, Ultrahuman hopes to change how people understand and improve their health. This round of funding gives the company the momentum it needs to continue building a smarter, more connected future for wellness.